Durable humoral responses after the second anti-SARS-CoV-2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors
- Resource Type
- Source
- British journal of haematologyREFERENCES. 197(1)
- Subject
COVID-19 Vaccines Leukemia, Myelogenous, Chronic, BCR-ABL Positive COVID-19 Humans Hematology Antibodies, Viral Protein Kinase Inhibitors - Language
- ISSN
- 1365-2141